跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,656 条关于
“Overall Survival”
全部
19,656
临床试验
9,030
药物
28
机构
57
资讯
10,541
去年
Pacritinib Response Is Associated With Overall Survival in ...
去年
Versamune HPV Shows Promising Survival Rates in Advanced Cervical Cancer Trial
2年前
RYBREVANT® Plus Chemotherapy Shows Positive Overall Survival Trend in EGFR-Mutated Lung Cancer
2年前
Durvalumab Demonstrates Improved Survival in Liver and Bladder Cancers
去年
Niraparib Maintenance Shows Sustained Progression-Free Survival Benefit in Advanced Ovarian Cancer, But No Overall Survival Improvement
去年
Pembrolizumab Plus Chemotherapy Improves Overall Survival in HER2-Positive Gastric Cancer
去年
Lurbinectedin Plus Atezolizumab Shows Survival Benefit in ES-SCLC Maintenance
2年前
Imfinzi Plus Imjudo Shows Unprecedented Survival in Advanced Liver Cancer
2年前
Imfinzi Plus Imjudo Shows Unprecedented 5-Year Survival in Advanced Liver Cancer
去年
Targeted Therapy and Immunotherapy Combination Improves Survival in Anaplastic Thyroid Cancer
第 1 页,共 1055 页
上一页
下一页